NasdaqGS - Nasdaq Real Time Price USD
Opthea Limited (OPT)
3.4100
+0.0500
+(1.49%)
At close: April 1 at 4:00:00 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
--
--
--
--
-45,546.1670
Operating Cash Flow
-161,015.3540
-161,015.3540
-120,608.3790
-71,334.9520
-45,546.1670
Investing Cash Flow
-33.4890
-33.4890
-21.9540
-16.9100
656.4820
Financing Cash Flow
243,728.8350
243,728.8350
167,285.1100
171.5970
116,936.2470
End Cash Position
172,471.3460
172,471.3460
89,188.7130
44,631.2930
118,193.1770
Income Tax Paid Supplemental Data
-14,636.9730
--
--
--
--
Interest Paid Supplemental Data
7.6800
--
--
--
--
Capital Expenditure
-33.4890
-33.4890
-21.9540
-16.9100
-12.7020
Issuance of Capital Stock
158,817.5140
158,817.5140
81,815.3580
--
105,477.5910
Repayment of Debt
-88.6790
-88.6790
-70.9660
-85.5780
-87.3730
Free Cash Flow
-161,048.8430
-161,048.8430
-120,630.3330
-71,351.8620
-45,558.8690
6/30/2021 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SVA Sinovac Biotech Ltd.
6.47
0.00%
OCS Oculis Holding AG
17.89
+0.62%
BSLNz.XC
CAMRF Camurus AB (publ)
59.98
0.00%
UCBJF UCB SA
150.70
0.00%
NEU.AX Neuren Pharmaceuticals Limited
11.34
+3.00%
KLDO Kaleido Biosciences, Inc.
0.0050
0.00%
EGTX.ST Egetis Therapeutics AB (publ)
3.8150
-3.17%
BINV.ST BioInvent International AB (publ)
29.15
+0.17%
AKTX Akari Therapeutics, Plc
1.4530
+6.06%